Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Other Non Operating Income (2023 - 2025)

Rallybio's Other Non Operating Income history spans 3 years, with the latest figure at $22.5 million for Q3 2025.

  • For Q3 2025, Other Non Operating Income rose 8855.78% year-over-year to $22.5 million; the TTM value through Sep 2025 reached $23.0 million, up 3751.34%, while the annual FY2024 figure was $744000.0, 183.97% up from the prior year.
  • Other Non Operating Income for Q3 2025 was $22.5 million at Rallybio, up from $118000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $22.5 million in Q3 2025 and bottomed at $35000.0 in Q4 2023.
  • The 3-year median for Other Non Operating Income is $143000.0 (2024), against an average of $2.2 million.
  • The largest YoY upside for Other Non Operating Income was 8855.78% in 2025 against a maximum downside of 17.48% in 2025.
  • A 3-year view of Other Non Operating Income shows it stood at $35000.0 in 2023, then skyrocketed by 422.86% to $183000.0 in 2024, then surged by 12183.61% to $22.5 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Other Non Operating Income are $22.5 million (Q3 2025), $118000.0 (Q2 2025), and $174000.0 (Q1 2025).